United States Functional Mushrooms Market Size & Outlook, 2025-2033
United States Functional Mushrooms Market Insights
- Based on Deep Market Insights findings, the United States Functional Mushrooms Market reached USD 7642.08 Million in 2024 and is estimated to attain USD 21007.01 Million by 2033.
- From 2026 to 2033, the United States market is expected to grow at a steady CAGR of 11.96%.
- Within the Mushroom Type category, Reishi dominated in 2024 in terms of market size contribution.
- Over the forecast period, Lion’s Mane is forecasted to deliver the fastest growth, positioning it as the most lucrative Mushroom Type segment.
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- As of 2024, United States held 23.52% of the global Functional Mushrooms Market size.
- By 2033, United States is anticipated to capture the largest share of the global Functional Mushrooms Market.
- In North America, United States is expected to lead the regional Functional Mushrooms Market size by 2033.
- United States will remain the fastest-growing market in North America, reaching USD 21124.07 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 7642.08 Million |
| Market Size In 2033 | USD 21007.01 Million |
| Largest segment | Reishi |
| Units | Revenue in USD Million |
| CAGR | 11.96% (2025-2033) |
| Segmnetation Covered | |
| Mushroom Type |
|
| Product Form |
|
| Health Benefit |
|
| End Use Industry |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United States Functional Mushrooms Market Mushroom Type 2025-2033 (USD Million)
| Mushroom Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reishi | XX.x | XX.x | XX.x | 4166.46 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Lion’s Mane | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Chaga | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United States Functional Mushrooms Market Product Form 2025-2033 (USD Million)
| Product Form | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Powder | XX.x | XX.x | XX.x | 3572.67 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Capsules | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Extract | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United States Functional Mushrooms Market Health Benefit 2025-2033 (USD Million)
| Health Benefit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Immunity | XX.x | XX.x | XX.x | 4201.62 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Cognitive Support | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Stress Relief | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United States Functional Mushrooms Market End Use Industry 2025-2033 (USD Million)
| End Use Industry | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dietary Supplements | XX.x | XX.x | XX.x | 3797.35 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Food | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Beverages | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.